How to buy Absci Corporation stock in Canada

Absci Corporation is a biotechnology business based in the US. Absci Corporation shares (ABSI) are listed on the NASDAQ and all prices are listed in US Dollars.

Its last market close was $2.99 – a decrease of 19.08% over the previous week. Absci Corporation employs 155 staff and has a trailing 12-month revenue of around $4.2 million.

Our top picks for where to buy Absci stock

Buy Absci Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Absci Corporation stock price (NASDAQ: ABSI)

Use our graph to track the performance of ABSI stocks over time.

Absci Corporation stocks at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$2.99
52-week range	$2.45 - $6.72
50-day moving average more info button	$3.61
200-day moving average more info button	$4.19
Wall St. target price	$8.38
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.93

Is it a good time to buy Absci Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Absci Corporation price performance over time

Historical closes compared with the close of $2.99 from 2024-12-20

1 week (2024-12-13)	-19.08%
1 month (2024-11-22)	16.80%
3 months (2024-09-20)	-30.79%
6 months (2024-06-21)	-0.99%

1 year (2023-12-22)	-9.94%
2 years (2022-12-22)	34.99%
3 years (2021-12-22)	8.81
5 years (2019-12-18)	N/A

Absci Corporation financials

Revenue TTM	$4.2 million
Gross profit TTM	$-39,804,000
Return on assets TTM	-27.4%
Return on equity TTM	-49.11%
Profit margin	0%
Book value	$1.76
Market Capitalization more info button	$349.2 million

TTM: trailing 12 months

Absci Corporation stock dividends

We're not expecting Absci Corporation to pay a dividend over the next 12 months.

You may also wish to consider:

• AstraZeneca PLC ADR (AZN.US) (2.3% forward annual dividend yield)

Absci Corporation stock price volatility

Over the last 12 months, Absci Corporation's stocks have ranged in value from as little as $2.45 up to $6.72. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Absci Corporation's is 2.187. This would suggest that Absci Corporation's stocks are significantly more volatile than the average for this exchange and represent a higher risk.

To put Absci Corporation's beta into context you can compare it against those of similar companies.

• Codiak BioSciences Inc (CDAK.US): 3.935
• AstraZeneca PLC ADR (AZN.US): 0.18

Absci Corporation overview

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; with AstraZeneca PLC for AI-driven drug discovery against an oncology target; and with Twist Bioscience Corporation to design a novel therapeutic using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington..

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Absci Corporation is owned by insiders or institutions?
Currently 20.088% of Absci Corporation stocks are held by insiders and 62.569% by institutions. How many people work for Absci Corporation?
Latest data suggests 155 work at Absci Corporation. When does the fiscal year end for Absci Corporation?
Absci Corporation's fiscal year ends in December. Where is Absci Corporation based?
Absci Corporation's address is: 18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683 What is Absci Corporation's ISIN number?
Absci Corporation's international securities identification number is: US00091E1091

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.